Jun Yu
Jun Yu
Tianjin Medical University Cancer Institute and Hospital
Adresă de e-mail confirmată pe tjmuch.com
Citat de
Citat de
Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia
M Kanda, H Matthaei, J Wu, SM Hong, J Yu, M Borges, RH Hruban, ...
Gastroenterology 142 (4), 730-733. e9, 2012
ATM Mutations in Patients with Hereditary Pancreatic Cancer
NJ Roberts, Y Jiao, J Yu, L Kopelovich, GM Petersen, ML Bondy, ...
Cancer discovery 2 (1), 41-46, 2012
MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance
T Moriyama, K Ohuchida, K Mizumoto, J Yu, N Sato, T Nabae, S Takahata, ...
Molecular cancer therapeutics 8 (5), 1067-1074, 2009
Deleterious germline mutations in patients with apparently sporadic pancreatic adenocarcinoma
K Shindo, J Yu, M Suenaga, S Fesharakizadeh, C Cho, A Macgregor-Das, ...
Journal of Clinical Oncology 35 (30), 3382, 2017
Targeted next‐generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas
E Amato, M Molin, A Mafficini, J Yu, G Malleo, B Rusev, M Fassan, ...
The Journal of pathology 233 (3), 217-227, 2014
The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma
PA Pérez-Mancera, AG Rust, L Van Der Weyden, G Kristiansen, A Li, ...
Nature 486 (7402), 266-270, 2012
MicroRNA array analysis finds elevated serum miR-1290 accurately distinguishes patients with low-stage pancreatic cancer from healthy and disease controls
A Li, J Yu, H Kim, CL Wolfgang, MI Canto, RH Hruban, M Goggins
Clinical cancer research 19 (13), 3600-3610, 2013
Survival in locally advanced pancreatic cancer after neoadjuvant therapy and surgical resection
G Gemenetzis, VP Groot, AB Blair, DA Laheru, L Zheng, AK Narang, ...
Annals of surgery 270 (2), 340, 2019
MicroRNA alterations of pancreatic intraepithelial neoplasias
J Yu, A Li, SM Hong, RH Hruban, M Goggins
Clinical cancer research 18 (4), 981-992, 2012
Defining and predicting early recurrence in 957 patients with resected pancreatic ductal adenocarcinoma
VP Groot, G Gemenetzis, AB Blair, RJ Rivero-Soto, J Yu, AA Javed, ...
Annals of surgery, 2019
MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell …
J Yu, K Ohuchida, K Mizumoto, N Sato, T Kayashima, H Fujita, K Nakata, ...
Molecular cancer 9, 1-10, 2010
Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages
J Yu, AL Blackford, M Dal Molin, CL Wolfgang, M Goggins
Gut 64 (11), 1783-1789, 2015
Gene expression levels as predictive markers of outcome in pancreatic cancer after gemcitabine-based adjuvant chemotherapy
H Fujita, K Ohuchida, K Mizumoto, S Itaba, T Ito, K Nakata, J Yu, ...
Neoplasia 12 (10), 807-IN8, 2010
Digital next-generation sequencing identifies low-abundance mutations in pancreatic juice samples collected from the duodenum of patients with pancreatic cancer and intraductal …
J Yu, Y Sadakari, K Shindo, M Suenaga, A Brant, JAN Almario, M Borges, ...
Gut 66 (9), 1677-1687, 2017
International Cancer Microbiome Consortium consensus statement on the role of the human microbiome in carcinogenesis
AJ Scott, JL Alexander, CA Merrifield, D Cunningham, C Jobin, R Brown, ...
Gut 68 (9), 1624-1632, 2019
MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion
J Yu, K Ohuchida, K Mizumoto, H Fujita, K Nakata, M Tanaka
Cancer biology & therapy 10 (8), 748-757, 2010
MicroRNA-203 expression as a new prognostic marker of pancreatic adenocarcinoma
N Ikenaga, K Ohuchida, K Mizumoto, J Yu, T Kayashima, H Sakai, H Fujita, ...
Annals of surgical oncology 17, 3120-3128, 2010
Down-regulation of deoxycytidine kinase enhances acquired resistance to gemcitabine in pancreatic cancer
S Ohhashi, K Ohuchida, K Mizumoto, H Fujita, T Egami, J Yu, H Toma, ...
Anticancer research 28 (4B), 2205-2212, 2008
Genetic analyses of isolated high‐grade pancreatic intraepithelial neoplasia (HG‐PanIN) reveal paucity of alterations in TP53 and SMAD4
W Hosoda, P Chianchiano, JF Griffin, ME Pittman, LAA Brosens, M Noë, ...
The Journal of pathology 242 (1), 16-23, 2017
α-Smooth muscle actin expressing stroma promotes an aggressive tumor biology in pancreatic ductal adenocarcinoma
H Fujita, K Ohuchida, K Mizumoto, K Nakata, J Yu, T Kayashima, L Cui, ...
Pancreas 39 (8), 1254-1262, 2010
Sistemul nu poate realiza operația în acest moment. Încercați din nou mai târziu.
Articole 1–20